FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023366508> ?p ?o ?g. }

• W2023366508 endingPage "552" @default.
• W2023366508 startingPage "544" @default.
• W2023366508 abstract "Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthalmological conditions, including ocular surface disorders such as the dry eye disease (DED). Since CsA is characterised by its low water solubility, the development of a topical ophthalmic formulation represents an interesting pharmaceutical question. In the present study, two different strategies to address this challenge were studied and compared: (i) a water-soluble CsA prodrug formulated within an aqueous solution and (ii) a CsA oil-in-water emulsion (Restasis®, Allergan Inc., Irvine, CA). First, the prodrug formulation was shown to have an excellent ocular tolerance as well as no influence on the basal tear production; maintaining the ocular surface properties remained unchanged. Then, in order to allow in vivo investigations, a specific analytical method based on ultra high pressure liquid chromatography coupled with triple quadrupole mass spectrometer (UHPLC–MS/MS) was developed and optimised to quantify CsA in ocular tissues and fluids. The CsA ocular kinetics in lachrymal fluid for both formulations were found to be similar between 15 min and 48 h. The CsA ocular distribution study evidenced the ability of the prodrug formulation to penetrate into the eye, achieving therapeutically active CsA levels in tissues of both the anterior and posterior segments. In addition, the detailed analysis of the in vivo data using a bicompartmental model pointed out a higher bioavailability and lower elimination rate for CsA when it is generated from the prodrug than after direct application as an emulsion. The interesting in vivo properties displayed by the prodrug solution make it a safe and suitable option for the treatment of DED." @default.
• W2023366508 created "2016-06-24" @default.
• W2023366508 creator A5001491891 @default.
• W2023366508 creator A5001527471 @default.
• W2023366508 creator A5001915103 @default.
• W2023366508 creator A5004746720 @default.
• W2023366508 creator A5011737122 @default.
• W2023366508 creator A5013683035 @default.
• W2023366508 creator A5053613435 @default.
• W2023366508 creator A5054173566 @default.
• W2023366508 creator A5061169398 @default.
• W2023366508 creator A5071473009 @default.
• W2023366508 creator A5075252318 @default.
• W2023366508 creator A5079241702 @default.
• W2023366508 date "2012-04-01" @default.
• W2023366508 modified "2023-10-18" @default.
• W2023366508 title "In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease" @default.
• W2023366508 cites W13787203 @default.
• W2023366508 cites W1501910640 @default.
• W2023366508 cites W1523354060 @default.
• W2023366508 cites W1966715871 @default.
• W2023366508 cites W1970999439 @default.
• W2023366508 cites W1971351734 @default.
• W2023366508 cites W1972788263 @default.
• W2023366508 cites W1982396311 @default.
• W2023366508 cites W1988255293 @default.
• W2023366508 cites W1992073724 @default.
• W2023366508 cites W1996921863 @default.
• W2023366508 cites W1998810752 @default.
• W2023366508 cites W2000687651 @default.
• W2023366508 cites W2002302351 @default.
• W2023366508 cites W2008653777 @default.
• W2023366508 cites W2012245891 @default.
• W2023366508 cites W2016682356 @default.
• W2023366508 cites W2017983804 @default.
• W2023366508 cites W2023903257 @default.
• W2023366508 cites W2028939973 @default.
• W2023366508 cites W2034254511 @default.
• W2023366508 cites W2043527396 @default.
• W2023366508 cites W2044606931 @default.
• W2023366508 cites W2045689556 @default.
• W2023366508 cites W2056795722 @default.
• W2023366508 cites W2064534678 @default.
• W2023366508 cites W2066392753 @default.
• W2023366508 cites W2067545345 @default.
• W2023366508 cites W2069842679 @default.
• W2023366508 cites W2072021875 @default.
• W2023366508 cites W2072027086 @default.
• W2023366508 cites W2082043748 @default.
• W2023366508 cites W2085204896 @default.
• W2023366508 cites W2093934346 @default.
• W2023366508 cites W2123444566 @default.
• W2023366508 cites W2128258034 @default.
• W2023366508 cites W2129689791 @default.
• W2023366508 cites W2153289041 @default.
• W2023366508 cites W2162065037 @default.
• W2023366508 cites W2162883325 @default.
• W2023366508 doi "https://doi.org/10.1016/j.ejpb.2011.11.017" @default.
• W2023366508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22155591" @default.
• W2023366508 hasPublicationYear "2012" @default.
• W2023366508 type Work @default.
• W2023366508 sameAs 2023366508 @default.
• W2023366508 citedByCount "32" @default.
• W2023366508 countsByYear W20233665082012 @default.
• W2023366508 countsByYear W20233665082013 @default.
• W2023366508 countsByYear W20233665082014 @default.
• W2023366508 countsByYear W20233665082015 @default.
• W2023366508 countsByYear W20233665082016 @default.
• W2023366508 countsByYear W20233665082017 @default.
• W2023366508 countsByYear W20233665082018 @default.
• W2023366508 countsByYear W20233665082019 @default.
• W2023366508 countsByYear W20233665082020 @default.
• W2023366508 countsByYear W20233665082021 @default.
• W2023366508 crossrefType "journal-article" @default.
• W2023366508 hasAuthorship W2023366508A5001491891 @default.
• W2023366508 hasAuthorship W2023366508A5001527471 @default.
• W2023366508 hasAuthorship W2023366508A5001915103 @default.
• W2023366508 hasAuthorship W2023366508A5004746720 @default.
• W2023366508 hasAuthorship W2023366508A5011737122 @default.
• W2023366508 hasAuthorship W2023366508A5013683035 @default.
• W2023366508 hasAuthorship W2023366508A5053613435 @default.
• W2023366508 hasAuthorship W2023366508A5054173566 @default.
• W2023366508 hasAuthorship W2023366508A5061169398 @default.
• W2023366508 hasAuthorship W2023366508A5071473009 @default.
• W2023366508 hasAuthorship W2023366508A5075252318 @default.
• W2023366508 hasAuthorship W2023366508A5079241702 @default.
• W2023366508 hasConcept C108215921 @default.
• W2023366508 hasConcept C110121322 @default.
• W2023366508 hasConcept C112705442 @default.
• W2023366508 hasConcept C134306372 @default.
• W2023366508 hasConcept C150903083 @default.
• W2023366508 hasConcept C155574463 @default.
• W2023366508 hasConcept C178790620 @default.
• W2023366508 hasConcept C181389837 @default.
• W2023366508 hasConcept C185592680 @default.
• W2023366508 hasConcept C207001950 @default.
• W2023366508 hasConcept C2778123984 @default.
• W2023366508 hasConcept C33923547 @default.

• next